News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
27,185 Results
Type
Article (1411)
Company Profile (386)
Press Release (25300)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (11996)
Career Advice (83)
Deals (1678)
Drug Delivery (2)
Drug Development (3306)
Employer Resources (4)
FDA (606)
Job Trends (776)
News (15786)
Policy (819)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (5)
2027 Genetown Standard (8)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (8)
Academia (62)
Academic (1)
Accelerated approval (5)
Adcomms (1)
Allergies (13)
Alliances (923)
ALS (8)
Alzheimer's disease (96)
Antibody-drug conjugate (ADC) (30)
Approvals (658)
Artificial intelligence (37)
ASCO (27)
Autoimmune disease (17)
Automation (5)
Bankruptcy (5)
Best Places to Work (812)
BIO (1)
BIOSECURE Act (2)
Biosimilars (19)
BioSpace Insights (1)
Biotechnology (280)
Bladder cancer (18)
Breast cancer (65)
Cancer (444)
Cardiovascular disease (42)
Career advice (76)
Career pathing (4)
CAR-T (20)
CDC (1)
CDMO (3)
Cell therapy (42)
Cervical cancer (5)
Clinical research (3330)
Collaboration (76)
Commercialization (1)
Company closure (1)
Compensation (71)
Complete response letters (3)
COVID-19 (190)
CRISPR (4)
C-suite (37)
Cystic fibrosis (9)
Data (718)
Depression (8)
Dermatology (11)
Diabetes (29)
Diagnostics (360)
Digital health (5)
Drug discovery (12)
Drug pricing (5)
Duchenne muscular dystrophy (11)
Earnings (11396)
Editorial (2)
Employer resources (5)
Events (2194)
Executive appointments (32)
FDA (915)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (54)
Gene editing (7)
Generative AI (2)
Gene therapy (18)
GLP-1 (63)
Government (140)
Guidances (134)
Healthcare (736)
Hematology (15)
HIV (6)
Huntington's disease (2)
IgA nephropathy (11)
Immunology and inflammation (13)
Immuno-oncology (5)
Indications (10)
Infectious disease (214)
Inflammatory bowel disease (9)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (11)
Interviews (9)
IPO (1240)
Job creations (105)
Job search strategy (64)
Kidney cancer (3)
Labor market (6)
Layoffs (20)
Leadership (5)
Legal (100)
Licensing (1)
Liver cancer (12)
Longevity (3)
Lung cancer (71)
Lymphoma (52)
Machine learning (2)
Management (1)
Manufacturing (43)
MASH (30)
Medical device (655)
Medtech (666)
Mergers & acquisitions (481)
Metabolic disorders (108)
mRNA (7)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (38)
Neuropsychiatric disorders (3)
Neuroscience (188)
NextGen: Class of 2026 (414)
Non-profit (64)
Obesity (40)
Opinion (5)
Ovarian cancer (14)
Pain (11)
Pancreatic cancer (37)
Parkinson's disease (25)
Partnered (2)
Patents (24)
Patient recruitment (22)
Peanut (2)
People (693)
Pharmaceutical (65)
Pharmacy benefit managers (2)
Phase 1 (749)
Phase 2 (1282)
Phase 3 (1601)
Pipeline (1322)
Policy (3)
Postmarket research (118)
Preclinical (177)
Press Release (2)
Prostate cancer (17)
Psychedelics (3)
Radiopharmaceuticals (15)
Rare diseases (62)
Real estate (138)
Recruiting (4)
Regulatory (846)
Reports (23)
Research institute (67)
Resumes & cover letters (8)
Rett syndrome (1)
RSV (6)
Schizophrenia (12)
Series A (4)
Series B (4)
Service/supplier (13)
Sickle cell disease (6)
Special edition (4)
Spinal muscular atrophy (5)
Sponsored (6)
Startups (72)
Stomach cancer (1)
The Weekly (2)
Vaccines (96)
Venture capital (3)
Weight loss (30)
Women's health (7)
Worklife (1)
Date
Last 7 days (17)
Last 30 days (85)
Last 365 days (2097)
2026 (1495)
2025 (2193)
2024 (2759)
2023 (2015)
2022 (2459)
2021 (2703)
2020 (2100)
2019 (1632)
2018 (1305)
2017 (1255)
2016 (915)
2015 (1072)
2014 (665)
2013 (405)
2012 (607)
2011 (539)
2010 (502)
Location
Africa (21)
Alabama (4)
Alaska (1)
Arizona (15)
Asia (2057)
Australia (141)
California (1221)
Canada (269)
China (91)
Colorado (39)
Connecticut (41)
Delaware (43)
Europe (4680)
Florida (143)
Georgia (40)
Hawaii (1)
Idaho (1)
Illinois (88)
India (28)
Indiana (60)
Iowa (2)
Japan (57)
Kansas (4)
Kentucky (7)
Louisiana (10)
Maine (10)
Maryland (117)
Massachusetts (768)
Michigan (26)
Minnesota (61)
Mississippi (1)
Missouri (14)
Montana (1)
Nevada (12)
New Hampshire (10)
New Jersey (341)
New York (219)
North Carolina (138)
Northern California (594)
Ohio (26)
Oregon (3)
Pennsylvania (214)
Puerto Rico (1)
Rhode Island (5)
South America (41)
South Carolina (2)
Southern California (392)
Tennessee (20)
Texas (136)
United States (3779)
Utah (39)
Virginia (10)
Washington D.C. (9)
Washington State (76)
Wisconsin (8)
27,185 Results for "91".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ainnocence Reports 91.4% Program Success Rate Across 58 Antibody Affinity Maturation Campaigns, Opens 28-Program Biologics Pipeline to Licensing
Structure-free AI platform delivers picomolar leads while cutting wet-lab validation to 20-50 samples per round
August 24, 2026
·
1 min read
Press Releases
North America Biotechnology Market to Capture USD 2168.91 Billion by 2035
May 4, 2026
·
1 min read
Press Releases
Radioligand Therapy (RLT) Market Worth $10.91 Billion by 2035, Growing at 13.2% CAGR
June 1, 2026
·
1 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
·
4 min read
Press Releases
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity
October 28, 2025
·
4 min read
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
·
4 min read
Press Releases
T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics towards the clinic
November 13, 2025
·
4 min read
Press Releases
Engineered T Cells Market Size Worth USD 616.91 Bn By 2034 Driven by Breakthroughs in Cancer Immunotherapy and Global Biotech Expansion
November 11, 2025
·
1 min read
Press Releases
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 5, 2025
·
4 min read
Press Releases
Genetic Testing Market Size Expected to Reach USD 91.30 Bn by 2034
December 2, 2024
·
1 min read
1 of 2,719
Next
